The transactions highlighted below are representative of Greenhill engagements. In addition, the Firm has completed many engagements that were not publicly-disclosed.
.
Recent Transactions
Sort By
27-Sep-23
Undisclosed
Target:
Slayback Pharma LLC
Acquiror:
Azurity Pharmaceuticals
Advised Azurity Pharmaceuticals, a pharmaceutical company specializing in the provision of innovative medicines to overlooked patients, on the acquisition of Slayback Pharma LLC ("Slayback"), a company focused on complex generic and specialty pharmaceutical products
30-Dec-22
$153 million
Target:
Annovera®, Imvexxy®, Bijuva®, and prescription prenatal vitamin products
Acquiror:
Mayne Pharma
Advised TherapeuticsMD, Inc., an innovative, leading women’s healthcare company on definitive agreements to license its products to Mayne Pharma
19-Aug-22
$2.2 billion
Target:
GI Alliance
Acquiror:
Apollo Hybrid Value Fund
Advising the management and majority physician owners of GI Alliance, the largest gastroenterology practice in the United States, on its recapitalization and buyout of minority partner, Waud Capital
05-May-22
Undisclosed
Target:
Airtower Networks
Acquiror:
DIF Capital Partners
Advised Airtower Networks on its strategic growth capital raise from DIF Capital Partners
19-Apr-22
Pending
$107 million
Target:
Syrah Resources
Acquiror:
U.S. Department of Energy
Advisor to Syrah Resources, an ASX-listed industrial minerals and technology company, on its US$107mm loan from the U.S. Department of Energy under the Advanced Technology Vehicles Manufacturing loan program to fund the initial expansion of its Vidalia active anode material facility in Louisiana, USA
01-Apr-22
$203 million
Target:
Monument Pipeline LP
Acquiror:
ARM Energy Holdings
Advised ARM Energy Holdings, an integrated North American energy services platform, on its acquisition and financing of Monument Pipeline LP, a Houston-based natural gas pipeline, from NextEra Energy Partners in a bilateral transaction
17-Sep-21
$750 million
Target:
MDC Texas Energy
Acquiror:
Maple Energy Holdings
Advised MDC Texas Energy in connection with its Chapter 11 bankruptcy and sale of substantially all of its oil and gas assets to Maple Energy Holdings pursuant to a plan of reorganization
19-Feb-21
$33 million
Target:
Acacia Pharma Group plc
Acquiror:
N/A
Advised Acacia Pharma Group plc, a US headquartered commercial stage biopharmaceutical company incorporated in England and listed in Belgium, on its placing of 10m new ordinary shares at a price of €2.70 per share
09-Feb-21
Undisclosed
Target:
US Acute Care Solutions
Acquiror:
Apollo Hybrid Value Fund
Advising US Acute Care Solutions, the largest majority physician-owned emergency medicine practice in the United States, on its recapitalization and buyout of minority partner, Welsh Carson
20-Jan-21
$1.9 billion
Target:
Extraction Oil and Gas
Acquiror:
N/A
Advised the Official Committee of Unsecured Creditors on the in-court restructuring of Extraction Oil and Gas, Inc., an Exploration and Production company focused on the Wattenberg Field of the Denver-Julesburg Basin
31-Dec-20
$1.2 billion
Target:
Pacific Drilling
Acquiror:
N/A
Advised Pacific Drilling, an international provider of offshore drilling services, on its pre-arranged Chapter 11 restructuring
01-Oct-20
$1.05 billion
Target:
Akorn, Inc.
Acquiror:
First Lien Term Loan Lenders
Advised Ad Hoc Group of First Lien Term Loan Lenders on Akorn’s in-court recapitalization
03-Sep-20
$789 million
Target:
Unit Corporation
Acquiror:
N/A
Advised the Ad Hoc Group of Noteholders on the prepackaged in-court restructuring of Unit Corporation
01-Jul-20
$22 billion
Target:
PG&E Corporation
Acquiror:
N / A
Advised Pension Benefit Guaranty Corporation (“PBGC”) in connection with PG&E’s in-court restructuring
17-Oct-19
$2.2 billion
Target:
American Energy – Permian Basin
Advised the independent Restructuring Committee of American Energy – Permian Basin (formerly known as Sable Permian Resources) in connection with its $2.2bn out-of-court recapitalization transaction
02-Nov-18
$NA
Target:
Pinnacle Midstream
Acquiror:
EagleClaw Midstream
Advised I Squared Capital on the contribution of Pinnacle Midstream, its Delaware Basin Midstream Company, to EagleClaw Midstream as part of the formation of a leading Delaware Basin Midstream Partnership with EagleClaw Midstream and Blackstone Energy Partners
02-May-18
$3.7 billion
Target:
Concordia International Corp.
Advised an Ad Hoc Group of Cross-over Debtholders on Concordia International’s cross-border Canadian restructuring and recapitalization, including a US$586.5mm common equity private placement, the equitization of ~US$1.7bn of unsecured debt and the partial paydown and exchange of ~US$2.2bn of secured debt
28-Mar-18
$NA
Target:
Willbros Group, Inc.
Acquiror:
Primoris Services Corporation
Advised Willbros Group, Inc., a specialty energy infrastructure contractor serving the power and oil & gas industries, on its sale to Primoris Services Corporation
29-Nov-17
$NA
Target:
Substantially all of the gas production and midstream assets of Energy Corporation of America
Acquiror:
Greylock Energy
Advised Energy Corporation of America, a natural gas producer focused on the Marcellus Shale, on the sale of substantially all its gas production and midstream assets to Greylock Energy, an affiliate of ArcLight Capital Partners
23-Feb-17
$1.1 billion
Target:
Natural Resource Partners L.P.
Advised Natural Resource Partners L.P., a publicly-traded master limited partnership that owns, manages and leases mineral properties in the United States, on a series of recapitalization transactions including the extension of NRP’s near-term debt maturities and the issuance of $250mm of new preferred equity capital to funds managed by Blackstone Tactical Opportunities and from several affiliates of GoldenTree Asset Management L.P.
04-Oct-16
$223 million
Target:
US rights to Toprol-XL (AstraZeneca)
Acquiror:
Aralez Pharmaceuticals Inc.
Advised Aralez Pharmaceuticals Inc., a global specialty pharmaceutical company in connection with the financing of its acquisition of the US rights to cardiovascular drug Toprol-XL (metoprolol succinate) and its Authorized Generic from AstraZeneca.
04-Oct-16
$32.0 billion
Target:
Texas Competitive Electric Holdings and its subsidiaries
Advised Texas Competitive Electric Holdings, Texas’ largest power generator and competitive retail electricity provider, and its subsidiaries at the direction of its independent director in connection with its and Energy Future Holdings’ Chapter 11 proceedings
09-Aug-16
$NA
Target:
Bionomics Limited
Advised ASX-listed Bionomics, a clinical stage biopharmaceutical company focused on the treatment of serious central nervous system disorders and cancer, on a consultation process with shareholders following calls for Board change, leading to the formation of a shareholder working group of leading institutional investors and company-led Board renewal.
26-May-16
$500 million
Target:
Apex International Energy Management LLC
Advised Apex International Energy Management, a newly formed oil and gas venture focused on the Middle East and North Africa regions, in the private equity fund-raising process with multiple energy-focused financial sponsors, ultimately resulting in an initial $500 million capital commitment from Warburg Pincus.
19-Jan-16
$NA
Target:
Recepta Biopharma
Acquiror:
Inova Empresa Fundo de Investimento em Participações
Advised Recepta Biopharma on a capital raise